Leggett & Platt, Incorporated designs, manufactures, and sells engineered components and products in the United States, Europe, China, Canada, Mexico, and internationally. The company offers steel rod, drawn wire, innersprings, specialty foam chemicals and additives, for use in bedding and furniture, semi-finished mattresses, private label finished mattresses, pillows and toppers, static foundations, adjustable beds, machines to produce innersprings, industrial sewing and quilting machines, and mattress-packaging and glue-drying equipment to industrial users of steel rod and wire, manufacturers of finished bedding, bedding brands and mattress retailers, e-commerce retailers, big box retailers, department stores, and home improvement centers. It also provides mechanical and pneumatic lumbar support and massage systems for automotive seating, seat suspension systems, motors and actuators, and cables; titanium, nickel, and stainless-steel tubing, formed tubes, tube assemblies, and flexible joint components for fluid conveyance systems; and engineered hydraulic cylinders to automobile original equipment manufacturers (OEMs) and suppliers, aerospace OEMs and suppliers, and mobile equipment OEMs. In addition, the company offers steel mechanisms and motion hardware; springs and seat suspensions; components and private label finished goods for soft seating; bases, columns, back rests, casters, and frames for office chairs and control devices; and carpet cushion and hard surface flooring underlayment, structural fabrics, and geo components for manufacturers of upholstered and office furniture, flooring retailers and distributors, contractors, landscapers, road construction companies, retailers, government agencies, mattress and furniture producers, and manufacturers of draperies, specialty packaging, filtration, and automotive upholstery. Leggett & Platt, Incorporated was founded in 1883 and is based in Carthage, Missouri.

Leggett & Platt Incorporated

RBC Capital analyst Leonid Timashev maintained a Buy rating on Legend Biotech on April 7 and set a price target of $62.00. The company’s shares clo...

RBC Capital Sticks to Their Buy Rating for Legend Biotech (LEGN)

Legend Biotech Corporation (($LEGN)) has held its Q4 earnings call. Read on for the main highlights of the call. Legend Biotech’s latest earnings c...

Legend Biotech Earnings Call Highlights CARVYKTI Momentum

Legacy Housing Corp (($LEGH)) has held its Q4 earnings call. Read on for the main highlights of the call. Legacy Housing Corp’s latest earnings cal...

Legacy Housing Corp Eyes Recovery After Tough 2025

In a report released today, Melinda Baxter from Morgan Stanley maintained a Buy rating on Coles Group, with a price target of A$24.00. According to...

Morgan Stanley Reaffirms Their Buy Rating on Coles Group (CLEGF)

The latest announcement is out from Coles Group ( ($AU:COL) ). Coles Group Limited has applied for quotation on the ASX of 1,004,921 new fully paid...

Coles Seeks ASX Quotation for Over 1 Million New Shares

Ord Minnett analyst maintained a Buy rating on Coles Group today and set a price target of A$22.50. Currently, the analyst consensus on Coles Group...

Ord Minnett Sticks to Its Buy Rating for Coles Group (CLEGF)

Legend Mining Limited ( ($AU:LEG) ) has issued an update. Legend Mining has advanced its Pinnacle Well Project, reporting that geophysical surveys ...

Legend Mining Advances Gold Target Definition at Pinnacle Well

The latest announcement is out from Coles Group ( ($AU:COL) ). Coles Group Limited has updated its notification to the ASX regarding a dividend on ...

Coles Updates Dividend Reinvestment Plan Pricing for January 2026 Period

Legend Mining Limited ( ($AU:LEG) ) has shared an announcement. Legend Mining has extended a key geophysical anomaly at its Pyrophyllite Hill prosp...

Legend Mining Extends High-Priority Gold Target at Pinnacle Well

The latest update is out from Legacy Gold Mines Ltd ( ($TSE:LEGY) ). Legacy Gold Mines has expanded the size of its previously announced non-broker...

Legacy Gold Upsizes Private Placement to Fund Idaho Baner Project

In a report released today, from B. Riley Securities maintained a Hold rating on Legacy Housing, with a price target of $21.00. In addition to B. R...

Legacy Housing (LEGH) Gets a Hold from B. Riley Securities

Coles Group ( ($AU:COL) ) just unveiled an announcement. Coles Group Limited has updated its notification to the ASX regarding an upcoming dividend...

Coles Updates ASX Dividend Notice With Revised Currency Details

Kepler Capital analyst Sven Sauer maintained a Buy rating on Allegroeu on March 12 and set a price target of PLN40.00. The company’s shares closed ...

Kepler Capital  Remains a Buy on Allegroeu (0A5O)

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Carvana Co (CVNA – Research Report) and Legac...

Analysts Are Bullish on Top Consumer Cyclical Stocks: Carvana Co (CVNA), Legacy Housing (LEGH)

Legend Mining Limited ( ($AU:LEG) ) has issued an update. Legend Mining Limited has called its annual general meeting for 1 May 2026 in West Perth,...

Legend Mining Sets 2026 AGM to Vote on Board, Pay and Incentive Plan

Legend Mining Limited ( ($AU:LEG) ) has issued an update. Legend Mining Limited has reaffirmed its commitment to strong corporate governance, empha...

Legend Mining Reasserts Alignment With Updated ASX Governance Standards

Legend Mining Limited ( ($AU:LEG) ) just unveiled an announcement. Legend Mining Limited has released its 2025 Annual Report, providing shareholder...

Legend Mining Releases Comprehensive 2025 Annual Report

In a report released yesterday, Rishi Jaluria from RBC Capital maintained a Buy rating on Legend Biotech, with a price target of $62.00. The compan...

RBC Capital Reaffirms Their Buy Rating on Legend Biotech (LEGN)

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Legend Biotech, with a price target of $78.00. Tenthoff c...

Piper Sandler Remains a Buy on Legend Biotech (LEGN)

In a report released on March 9, Thomas Neuhold from Kepler Capital maintained a Buy rating on LEG Immobilien, with a price target of €113.00. The ...

Current Quarter	$0.26	Next Quarter	$0.31
Current Year	$1.08	Next Year	$1.17
QoQ Growth	+19.2%	YoY Growth	+8.3%
3Y EPS CAGR	-48.3%	Target Price	$12.50
Consensus	Buy	Upside	+24.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LEG	$10.07	0.00%	1.13M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LEG	$10.07	0%	1.13M
3
4
5
6

LEG

LEG

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Leggett & Platt Incorporated Data in Excel

Get Leggett & Platt Incorporated Data in Excel